IP Library Granted Patent US 11,065,365
Granted Patent B2
US 11,065,365 · App. 16/856,031 · Granted Jul 20, 2021

Preparation and/or formulation of proteins cross-linked with polysaccharides

Inventor: Jens Sommer-Knudsen (Gordon, AU)
Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
A61L27/227A61K8/64A61K8/735A61L27/20A61L27/22A61L27/26A61L27/50A61L27/58A61Q19/08C07K14/765C07K14/78C08B11/08C08B11/12C08B33/04C08B37/0009C08B37/0021C08B37/0024C08B37/0033C08B37/0063C08B37/0069C08B37/0072C08B37/0075C08B37/0084C08B37/0096C08H1/00C08H1/06C08L1/28C08L1/284C08L1/286C08L3/14C08L5/00C08L5/02C08L5/04C08L5/08C08L5/10C08L89/00C08L89/06A61K2800/91A61L2400/06A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,365
App. No.
16/856,031
Granted
Jul 20, 2021
Kind
B2
Abstract

Therapeutic compositions and/or formulations are provided, comprising: at least one cross-linked protein matrix, wherein the at least one cross-linked protein matrix comprises at least one protein residue and at least one saccharide-containing residue, and methods of producing the same. The cross-linked protein matrix may be derived from cross-linking a full length or substantially full length protein, such as tropoelastin, elastin, albumin, collagen, collagen monomers, immunoglobulins, insulin, and/or derivatives or combinations thereof, with a saccharide containing cross-linking agent, such as a polysaccharide cross-linking agent derived from, for example, hyaluronic acid or a cellulose derivative. The therapeutic compositions may be administered topically or by injection. The present disclosure also provides methods, systems, and/or kits for the preparation and/or formulation of the compositions disclosed herein.

Claims (34)

1. A kit comprising:

(a) a prefilled syringe, wherein the prefilled syringe is filled with a tissue compatible composition comprising a protein selected from the group consisting of tropoelastin and albumin; a hyaluronic acid cross-linking molecule comprising one or more carboxyl groups; and at least one intermolecular cross-linkage comprising an amide bond between an amine of the protein and a carboxyl group of the hyaluronic acid cross-linking molecule; and

(b) instructions for use.

2. The kit of claim 1 , further comprising an assortment of appropriate sized needles.

3. The kit of claim 2 , wherein the assortment of appropriately sized needles comprise fine gauge needles.

4. The kit of claim 3 , wherein the needles range from about 25 gauge to about 31 gauge.

5. The kit of claim 2 , wherein the needles range from about 18 gauge to about 31 gauge.

6. The kit of claim 1 , further comprising a needle delivery system.

7. The kit of claim 6 , wherein the needle delivery system is selected from a needle roller ball type system, an automatic injection pen type system, and a mesotherapy injection gun type system.

8. The kit of claim 4 , wherein the needle delivery system is an automatic injection pen type system.

9. The kit of claim 1 , wherein the protein is tropoelastin.

10. The kit of claim 1 , wherein the composition retains a coherent structure and is sufficiently cross-linked to slow the composition's resorption in vivo.

11. The kit of claim 1 , wherein the composition is one or more of bioavailable, biodegradable, bioabsorbable, or bioresorbable.

12. The kit of claim 1 , wherein the composition is useful in bulking tissue, augmenting tissue, or combinations thereof.

13. The kit of claim 1 , wherein the composition is used in a dermatological or cosmetological application.

14. The kit of claim 1 , wherein the composition is used in one or more of restorative surgery, dermatological surgery, eye surgery, plastic surgery, vascular surgery, reconstructive surgery, orthopedic surgery, tissue augmentation, supplementation of a body cavity or a deficit, and restoring volume effused during surgery.

15. A kit comprising:

(a) a prefilled syringe, wherein the prefilled syringe is filled with a tissue compatible composition comprising tropoelastin; a hyaluronic acid cross-linking molecule comprising one or more carboxyl groups; and at least one intermolecular cross-linkage comprising an amide bond between an amine of the protein and a carboxyl group of the hyaluronic acid cross-linking molecule;

(b) one or more needles of a size selected from 25 gauge, 26 gauge, 27 gauge, 28 gauge, 29 gauge, 30 gauge and 31 gauge; and

(c) instructions for use.

16. A kit comprising:

(a) a syringe;

(b) at least one separate container, wherein the separate container is filled with a tissue compatible composition comprising a protein selected from the group consisting of tropoelastin and albumin; a hyaluronic acid cross-linking molecule comprising one or more carboxyl groups; and at least one intermolecular cross-linkage comprising an amide bond between an amine of the protein and a carboxyl group of the hyaluronic acid cross-linking molecule;

(c) a needle delivery system; and

(d) instructions for use.

17. The kit of claim 16 , wherein the needle delivery system is a selected from a needle, a needle roller ball type system, an automatic injection pen type system, and a mesotherapy injection gun type system.

18. The kit of claim 17 , wherein the needle delivery system is a needle with a size range from about 25 gauge to about 31 gauge.

19. The kit of claim 17 , wherein the needle delivery system is an automatic injection pen type system.

20. The kit of claim 16 , wherein the protein is tropoelastin.

21. The kit of claim 16 , wherein the composition retains a coherent structure and is sufficiently cross-linked to slow the composition's resorption in vivo.

22. The kit of claim 16 , wherein the composition is one or more of bioavailable, biodegradable, bioabsorbable, or bioresorbable.

23. The kit of claim 16 , wherein the composition is useful in bulking tissue, augmenting tissue, or combinations thereof.

24. The kit of claim 16 , wherein the composition is used in a dermatological or cosmetological application.

25. The kit of claim 16 , wherein the composition is used in one or more of restorative surgery, dermatological surgery, eye surgery, plastic surgery, vascular surgery, reconstructive surgery, orthopedic surgery, tissue augmentation, supplementation of a body cavity or a deficit, and restoring volume effused during surgery.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2021
From: SOMMER-KNUDSEN, JENS
To: ELASTAGEN PTY LTD
Reel/Frame 056581/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: ELASTAGEN PTY LTD
To: ALLERGAN AUSTRALIA PTY LTD
Reel/Frame 052611/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: ALLERGAN AUSTRALIA PTY LTD
To: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 052611/0604 →